DarioHealth to Host Fourth Quarter and Year End 2017 Conference Call on March 20, 2018

    Earnings and Business Update Conference Call Scheduled for 9:00am EDT

    Mar 8, 2018

    NEW YORK and CAESAREA, Israel, March 8, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its fourth quarter and year end 2017 results on Tuesday, March 20th and host a conference call the same morning at 9:00am EDT. The Company will discuss its fourth quarter and year end 2017 operating and financial results and its strategy and outlook for 2018. The conference call will be hosted by Erez Raphael, Chief Executive Officer, and Zvi Ben-David, Chief Financial Officer. The live conference call can be accessed by dialing 1-877-407-8035 or 1-201-689-8035 (international). Participants should ask for the DarioHealth Earnings Conference Call. The conference call will also be available via live webcast at: http://www.investorcalendar.com/event/26834

    DarioHealth Logo

    Conference Call Details:
    Date: Tuesday, March 20, 2018  
    Time: 9:00am EDT  
    Dial-in Number: 1-877-407-8035  
    International Dial-in Number: 1-201-689-8035  
    Webcast: http://www.investorcalendar.com/event/26834

    Participants are recommended to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through April 3, 2018. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 26834. The webcast replay will be available through June 20, 2017.

    About DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital health company serving its users with dynamic mobile health solutions. In today's day and age, knowledge of health and treatment is being democratized, and we believe people deserve to know everything about their own health and have the best tools to manage their condition. DarioHealth employs a revolutionary approach whereby harnessing big data, we have developed a novel method for chronic disease data management, empowering people to analyze and personalize self-diabetes management in a totally new way without having the disease slow them down. DarioHealth has a commercial office in New York with an R&D center in Caesarea, Israel. For more information, visit http://mydario.investorroom.com/.

    DarioHealth Corporate Contact: Shmuel Herschberg, Marketing Director, shmuel@mydario.com, +1-914-775-5548

    DarioHealth Public Relations Contact: Terese Kelly, Rosica PR, terese@rosica.com, +1-201-843-5600

    DarioHealth Investor Relations Contact: Westwicke Partners, Dario@Westwicke.com, +1-443-213-0500

     

    SOURCE DarioHealth Corp.


    print email rss